| 摘要: |
| 左氧氟沙星片是仿制药申报和一致性评价的热门品种。本文就左氧氟沙星片生物等效性试验豁免的政策法规以及指导原则进行了论述,总结了不同规格的左氧氟沙星片生物等效性试验豁免的技术要求,旨在为研究单位提供更好的研发和申报思路。 |
| 关键词: 左氧氟沙星片 生物等效性试验 豁免 规格 |
| DOI:10.13506/j.cnki.jpr.2024.12.010 |
| 基金项目: |
|
Publication Date:December 25, 2024
|
|
| Consideration of bioequivalence test waiver of Levofloxacin Tablets |
| ZHAO Lei |
| (Center for Drug Evaluation, National Medical Products Administration , Beijing 100076,China) |
| Abstract: |
| Generic drug application and consistency evaluation of levofloxacin tablets are popular in recent years. This article discusses the policies and guiding principle of bioequivalence test waiver,and summarizes the technical requirements of bioequivalence test waiver for different specifications of Levofloxacin Tablets,in order to provide better research and application route for research unit. |
| Key words: Levofloxacin tablets Bioequivalence test Waiver Specifications |